TP
At a glance
Status
Inactive
last filed Apr 2025
Clients
0
past 12 months
Filings
0
0 agencies · past 12 months
Activity
filings by quarter
Background
Career
AP
Government experience
Intelligence Professional
OUSD
I&S) (2023-24); Deputy COS/LD, Rep. Steube (2023-2020); Sr. LA/MLA, Rep. Steube (2019-20); Sr. LA, Rep. Rothfus (2018-19); LA, Rep. Rothfus (2017-18); LC/EA, Rep. Rothfus (2015-17); Intern, Rep. Womack (2014-15
Disclosed on LD-2 filings
Specific issues
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program. Issues related to biopharmaceutical intellectual property and patent matters.
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (Pub. L. No. 117-169), including implementation. Issues related to the Small Biotech Innovation Act (S. 5029, 118th Congress).
Issues related to research and development (R&D) tax credits.
Issues relating to tax parity proposals for BDC investors.
Issues relating to the regulation of business development companies.
Issues pertaining to the National Housing Act, Housing Supply Action Plan, and monitoring offsite constructed housing policy.
Clients
No client work disclosed in the past 12 months.
Past clients6
Filings · past 12 months
Nothing filed in the past 12 months.
Older filings13
EXELIXIS, INC.
ENDEAVORS
COVENTBRIDGE (USA) LLC DBA COVENTBRIDGE INTEGRITY SYSTEMS
FIRST STEP HOMES
AMERICA'S FRONTIER FUND
BLUE OWL CAPITAL HOLDINGS LLC
COVENTBRIDGE (USA) LLC DBA COVENTBRIDGE INTEGRITY SYSTEMS
BLUE OWL CAPITAL HOLDINGS LLC
EXELIXIS, INC.
ENDEAVORS
AMERICA'S FRONTIER FUND
ENDEAVORS
BLUE OWL CAPITAL HOLDINGS LLC